Retraction of

• A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity.

  Meyer T, Regenass U, Fabbro D, Alteri E, Rösel J, Müller M, Caravatti G, Matter A. Meyer T, et al. Int J Cancer. 1989 May 15;43(5):851-6. doi: 10.1002/ijc.2910430519. Int J Cancer. 1989. Retraction in: Int J Cancer. 1999 May 17;81(4):669. doi: 10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.0.co;2-f. PMID: 2714889 Retracted.